Northwest Biotherapeutics (NWBO) EPS (Basic) Growth (5y) (2015 - 2026)
Northwest Biotherapeutics (NWBO) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.41 Bn | 466.62 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.15 Bn | 114.90 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.94 Bn | 61.18 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.43 Bn | 62.43 Bn | - |
| 8 | Argenx Se | 55.85 Bn | 50.67 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Northwest Biotherapeutics | 277.35 Mn | 275.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.74% |
| Dec 31, 2025 | 14.87% |
| Sep 30, 2025 | 41.22% |
| Jun 30, 2025 | 33.18% |
| Mar 31, 2025 | -40.72% |
| Dec 31, 2024 | -361.97% |
| Sep 30, 2024 | -7.46% |
| Jun 30, 2024 | -109.01% |
| Mar 31, 2024 | -231.68% |
| Dec 31, 2023 | -297.81% |
| Sep 30, 2023 | -310.44% |
| Jun 30, 2023 | -197.28% |
| Mar 31, 2023 | -158.68% |
| Dec 31, 2022 | -199.09% |
| Sep 30, 2022 | -228.36% |
| Jun 30, 2022 | -259.54% |
| Mar 31, 2022 | -185.48% |
| Dec 31, 2021 | 275.11% |
| Sep 30, 2021 | 81.94% |
| Jun 30, 2021 | 102.40% |